Schwab Charles CORP Form 4 insider transactions

NYSE
Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, reported the sale of common stock on August 15 and 16, 2024, according to a Form 4 filing with the SEC.
NYSE
Paul Woolway, MD and Chief Banking Officer of Schwab, reports a sale of common stock and updates on beneficial ownership, including holdings in trust and ESPP.
NYSE
Charles Schwab, Co-Chairman of Charles Schwab Corp, exercised stock options and transferred the resulting shares to a living trust.
NYSE
Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on July 19, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Walter Bettinger, Co-Chairman and CEO of Schwab, recently purchased 25,000 shares of Schwab stock at a price of $66.26 per share.
NYSE
Richard Wurster, President of Charles Schwab Corp, recently purchased 10,000 shares of the company's common stock at an average price of $62.0454.
NYSE
Jonathan Beatty, MD, Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged trading plan.
NYSE
Charles A. Ruffel, a director at Charles Schwab Corp, acquired 1,632 nonqualified stock options on July 1, 2024, in lieu of cash compensation.
NYSE
Director Bharat Masrani acquired 409 Restricted Stock Units (RSUs) in Schwab Charles Corp on July 1, 2024, through the Directors' Deferred Compensation Plan II.
NYSE
Director Marianne Catherine Brown acquired 511 Restricted Stock Units (RSUs) in Charles Schwab Corp on July 1, 2024, under the Directors' Deferred Compensation Plan II.
NYSE
Stephen A. Ellis, a director of Charles Schwab Corp, acquired 1,836 nonqualified stock options on July 1, 2024, in lieu of cash compensation.
NYSE
Director Frank C Herringer acquired 2,244 nonqualified stock options of Schwab Charles Corp on July 1, 2024, in lieu of cash compensation.
NYSE
Jonathan S. Beatty, MD, Head of Advisor Services at Charles Schwab Corp, reports the acquisition of 11,191 shares of common stock through a restricted stock unit grant.
NYSE
Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) on June 20, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Bernard J. Clark, MD Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director John K. Adams Jr. reported the acquisition of common stock and nonqualified stock options in Charles Schwab Corp.
NYSE
Charles A. Ruffel, a director at Charles Schwab Corp, reported the acquisition of restricted stock units and a nonqualified stock option, along with dividend reinvestments.
NYSE
Director Todd M. Ricketts reports the acquisition of restricted stock units and nonqualified stock options in Charles Schwab Corporation under the company's 2022 Stock Incentive Plan.
NYSE
Bernard J. Clark, MD Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares on May 28, 2024, according to a recent SEC filing.
NYSE
Director Gerri Martin-Flickinger received stock and option grants from Charles Schwab on May 28, 2024, according to a recent SEC filing.
NYSE
Director Paula A. Sneed reports acquisition of restricted stock units and stock options in Charles Schwab Corp.
NYSE
Carolyn Schwab-Pomerantz, a director of Charles Schwab Corp, reported the acquisition of restricted stock units and stock options in a recent SEC filing.
NYSE
Director Arun Sarin reports the acquisition of restricted stock units and stock options in Charles Schwab Corp.
NYSE
Director Bharat Masrani reports the acquisition of restricted stock units and nonqualified stock options in Schwab.
NYSE
Director Brian M. Levitt reported the acquisition of common stock and nonqualified stock options in Charles Schwab Corp on May 28, 2024.
NYSE
Director Frank Herringer reports receiving stock and option grants from Schwab on May 28, 2024.
NYSE
Director Stephen Ellis reports the acquisition of restricted stock units and stock options in Charles Schwab Corporation.
NYSE
Christopher V. Dodds, a director at Charles Schwab Corp, received stock and option grants under the company's 2022 Stock Incentive Plan.
NYSE
Director Joan Dea receives stock and option grants under Charles Schwab's 2022 Stock Incentive Plan.
NYSE
Marianne C. Brown, a director at Charles Schwab Corp, was granted stock options and restricted stock units under the company's 2022 Stock Incentive Plan.